483 Spirit Pharmaceuticals Jan 2017

483 Spirit Pharmaceuticals Jan 2017

$119 - Not in Stock

FDA investigators audited the Spirit Pharmaceuticals - Ronkonkoma, NY, United States facility and issued inspectional observations (via FDA 483) on 25 Jan 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2017
  • Location: Ronkonkoma, United States
  • FEI: 3011773798
Order